Xiaofang et al. 2023. Anti-programmed cell death 1 or Anti-programmed cell death ligand 1 vs. Sunitinib for the management of advanced renal cell carcinoma ：a meta-analysis. American Journal of Translational Medicine. 7, 1 (Mar. 2023), 55–63.